Study suggests molecular imaging strategy for determining molecular classifications of NSCLC
Researchers developed a novel small molecule PET tracer to noninvasively detect EGFR mutation status in NSCLC patients. The approach showed high accuracy and potential for predicting treatment response and monitoring dynamic changes during therapy.
SourceMolecular Imaging Research Center (MIRC) of Harbin Medical University·JournalScience Translational Medicine·DateMar 7, 2018